BTG3 and systemic lupus erythematosus: In terms of clinical diagnoses, two patients (2.8% of ANA-negative, ENA-positive patients) were diagnosed with ANA-negative SLE based upon their compelling constellation of clinical features, one of 72 patients (1.4%) met criteria for anti-synthetase syndrome and one was felt to have a UCTD.